HomePharma

Pharma

Pharma

Altesa BioSciences, Inc., Launches Operations to Develop, Commercialize Drugs for Respiratory Viruses and Global Viral Threats

Life Sciences Times - 0
Pharma

Virpax Reports Favorable Preclinical Safety Data for Envelta™ for the Treatment of Acute and Chronic Pain

Life Sciences Times - 0
Pharma

Phase 3 Clinical Trial Confirms SaNOtize’s Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India

Life Sciences Times - 0
Pharma

Silence Therapeutics Announces Positive Topline Data in SLN360 Phase 1 Single-Ascending Dose Study in Healthy Adults with High Lipoprotein(a)

Life Sciences Times - 0
Pharma

Sunovion and Otsuka Initiate Phase 3 Clinical Development of Non-Racemic Amisulpride for the Treatment of People with Bipolar Depression

Life Sciences Times - 0
Pharma

Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs

Life Sciences Times - 0
Pharma

n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases

Life Sciences Times - 0
Pharma

CANbridge Reports Positive Top-Line CAN106 Phase 1 Data

Life Sciences Times - 0
Pharma

Regio Biosciences Enters into License Agreement with AstraZeneca for Phase 2a Asset in Peripheral Artery Disease (PAD)

Life Sciences Times - 0
Pharma

EuBiologics: Phase III Clinical Trial IND Approval of EuCorVac-19, COVID-19 Vaccine Candidate, in South Korea

Life Sciences Times - 0
Pharma

UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Life Sciences Times - 0
Pharma

NorthSea Therapeutics Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease

Life Sciences Times - 0
1...606162...91Page 61 of 91

Most Read